Viking Therapeutics, Inc.VKTXNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Above historical average, modest growth trend.
Left:
||||
Price-to-book ratio
Latest
4.98
↑ 44% above average
Average (9y)
3.47
Historical baseline
Range
High:7.83
Low:1.48
CAGR
+8.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 4.98 | -1.1% |
| 2023 | 5.04 | +1.4% |
| 2022 | 4.97 | +182.5% |
| 2021 | 1.76 | +5.2% |
| 2020 | 1.67 | -19.7% |
| 2019 | 2.08 | +40.8% |
| 2018 | 1.48 | -81.1% |
| 2017 | 7.83 | +225.2% |
| 2016 | 2.41 | -3.0% |
| 2015 | 2.48 | - |